General Anti-Infectives For Systemic Use, Vaccines, Antineoplastic And Immunodulating Agents – Bévacizumab. The Market Concerns Supplies Of The Pharmaceutical Specialty Containing The Active Ingredient “Bevacizumab” For Injection In “Ready To Use” Vials Of 100Mg And 400Mg.
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
